Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Prostate”

1,124 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,124 results

Not applicableStudy completedNCT03707574
What this trial is testing

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

Who this might be right for
Advanced Malignant NeoplasmAdvanced MelanomaAdvanced Renal Cell Carcinoma+51 more
National Cancer Institute (NCI) 64
Testing effectiveness (Phase 2)Looking for participantsNCT07025369
What this trial is testing

Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial

Who this might be right for
Prostate AdenocarcinomaStage IIC Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8+1 more
Mayo Clinic 30
Post-approval studies (Phase 4)Study completedNCT05803096
What this trial is testing

Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain

Who this might be right for
Prostate DiseaseMalignancyBenign Prostatic Hyperplasia+4 more
Beth Israel Deaconess Medical Center 143
Large-scale testing (Phase 3)Study completedNCT00936390
What this trial is testing

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,538
Testing effectiveness (Phase 2)Study completedNCT00242918
What this trial is testing

Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
Benaroya Research Institute 29
Large-scale testing (Phase 3)Study completedNCT00331773
What this trial is testing

Radiation Therapy in Treating Patients With Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,116
Testing effectiveness (Phase 2)Ended earlyNCT02431260
What this trial is testing

An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies

Who this might be right for
Solid Tumors and Hematologic Malignancy
Incyte Corporation 69
Large-scale testing (Phase 3)Study completedNCT02673151
What this trial is testing

68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment

Who this might be right for
Prostate AdenocarcinomaPSA FailureRecurrent Prostate Carcinoma
Andrei Iagaru 61
Large-scale testing (Phase 3)Study completedNCT00002881
What this trial is testing

Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Ended earlyNCT04951492
What this trial is testing

Olaparib for the Treatment of Castration Resistant Prostate Adenocarcinoma

Who this might be right for
Castration-Resistant Prostate CarcinomaProstate Adenocarcinoma
University of Washington 2
Large-scale testing (Phase 3)Study completedNCT00134056
What this trial is testing

S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy

Who this might be right for
Metastatic CancerProstate Cancer
SWOG Cancer Research Network 1,038
Testing effectiveness (Phase 2)Study completedNCT00083005
What this trial is testing

Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate

Who this might be right for
Prostate Cancer
National Institutes of Health Clinical Center (CC) 60
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Testing effectiveness (Phase 2)Ended earlyNCT00459810
What this trial is testing

Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 21
Not applicableStudy completedNCT02523924
What this trial is testing

Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical Prostatectomy

Who this might be right for
Adenocarcinoma of the Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03624660
What this trial is testing

Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
University of Florida 100
Large-scale testing (Phase 3)UnknownNCT00110162
What this trial is testing

Androgen Deprivation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Peter MacCallum Cancer Centre, Australia 2,000
Not applicableActive Not RecruitingNCT04258813
What this trial is testing

Onco-primary Care Networking to Support TEAM-based Care

Who this might be right for
Blood PressureHypertensionCancer+15 more
Duke University 313
Testing effectiveness (Phase 2)Study completedNCT00940225
What this trial is testing

Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

Who this might be right for
Solid TumorsCancer
Exelixis 730
Testing effectiveness (Phase 2)Looking for participantsNCT05616650
What this trial is testing

Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor

Who this might be right for
Prostatic NeoplasmsProstate CancerProstate Adenocarcinoma
National Cancer Institute (NCI) 42
Next Page